Lara Goldstein

Benzinga Insider Report is your secret to a profitable week. While most traders scramble and waste hours on research and analysis—you'll have expert

Zinger Key Points A comprehensive weekly overview of major moves in business, science, trends and events within the psychedelics sector.

DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design - Algernon Pharmaceuticals (OTC:AGN

Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim A

Zinger Key Points Russell Newcombe was a renowned supporter and promoter of harm reduction strategies for drug consumers worldwide.

Zinger Key Points Optimi's natural psilocybin to be assessed on a first-of-kind clinical study on Māori patients in a New Zealand.

Podcast: Expert Talks About 'Kanna,' The Legal African Succulent That Elevates Awareness, Concentration A

Zinger Key Points The company's strategic review involves sharpening its focus on U.S. operations and strategic adjustments in the Canadian market.

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024.

Zinger Key Points A comprehensive biweekly overview of major moves in business, science, trends and events in the psychedelics sector.